American consumers cannot purchase prescription drugs with the certainty that the products are safe and effective.
Editor's note · Context
Burgess highlights the ongoing safety concerns in the drug supply chain.
Share
More from Michael Burgess
I thank Dr. Bucshon from Indiana for yielding me the time on such an important reauthorization that we are undertaking today. Mr. Speaker, 2018 was the last authorization for sickle cell research. Prior to that, it had been part of the…
I am going to yield to Mr. Alford here in just a moment, but let me yield myself 2 minutes for the purpose of a response. It is difficult for me to sit here and be lectured about the cost of living by the gentleman from Massachusetts…
I thank the gentleman from Kentucky (Mr. Massie), my friend, for yielding time. Mr. Speaker, I do rise today in support of the rule and the underlying legislation. It is a new day in the House of Representatives, and I intend to make…
Last night the House Committee on Rules met to report a rule providing for consideration of H.R. 115, the Midnight Rules Relief Act under a closed rule. The rule provides for 1 hour of general debate equally divided between the chair and…





